Pike V. W., McCarron J. A., Lammerstma A. A., Hume S. P., Poole K., Grasby P. M., Malizia A., Cliffe I. A., Fletcher A., Bench C. J. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635 (англ.) // Eur. J. Pharmacol.[англ.] : journal. — 1995. — Vol. 283, no. 1—3. — P. R1—3. — doi:10.1016/0014-2999(95)00438-Q. — PMID7498295.
Price J. C., Kelley D. E., Ryan C. M., Meltzer C. C., Drevets W. C., Mathis C. A., Mazumdar S., Reynolds C. F. Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study (англ.) // Brain Res.[англ.] : journal. — 2002. — Vol. 927, no. 1. — P. 97—103. — doi:10.1016/S0006-8993(01)03297-8. — PMID11814436.
Burnet P. W., Eastwood S. L., Harrison P. J. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia (англ.) // Neurochem. Int.[англ.] : journal. — 1997. — Vol. 30, no. 6. — P. 565—574. — doi:10.1016/S0197-0186(96)00124-6. — PMID9152998.
Griebel G., Misslin R., Pawlowski M., Guardiola Lemaître B., Guillaumet G., Bizot-Espiard J. Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice. (англ.) // Neuroreport. : journal. — 1992. — Vol. 3, no. 1. — P. 84—86. — doi:10.1097/00001756-199201000-00022. — PMID1351756.
Simon P., Guardiola B., Bizot-Espiard J., Schiavi P., Costentin J. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists. (англ.) // Psychopharmacology[англ.] : journal. — Springer, 1992. — Vol. 108, no. 1—2. — P. 47—50. — doi:10.1007/BF02245284. — PMID1357709.
Astier B., Lambás Señas L., Soulière F., Schmitt P., Urbain N., Rentero N., Bert L., Denoroy L., Renaud B., Lesourd M., Muñoz C., Chouvet G. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. (англ.) // Eur J Pharmacol.[англ.] : journal. — 2003. — Vol. 459, no. 1. — P. 17—26. — doi:10.1016/S0014-2999(02)02814-5. — PMID12505530.
Bardin L., Tarayre J. P., Malfetes N., Koek W., Colpaert F. C. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain (англ.) // Pharmacology : journal. — 2003. — April (vol. 67, no. 4). — P. 182—194. — doi:10.1159/000068404. — PMID12595749.
Bruins Slot L. A., Koek W., Tarayre J. P., Colpaert F. C. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640 (англ.) // European Journal of Pharmacology[англ.] : journal. — 2003. — April (vol. 466, no. 3). — P. 271—279. — doi:10.1016/S0014-2999(03)01566-8. — PMID12694810.
Bardin L., Assié M. B., Pélissou M., Royer-Urios I., Newman-Tancredi A., Ribet J. P., Sautel F., Koek W., Colpaert F. C. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 2005. — March (vol. 312, no. 3). — P. 1034—1042. — doi:10.1124/jpet.104.077669. — PMID15528450.
Deseure K., Bréand S., Colpaert F. C. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist (англ.) // European Journal of Pharmacology[англ.] : journal. — 2007. — July (vol. 568, no. 1—3). — P. 134—141. — doi:10.1016/j.ejphar.2007.04.022. — PMID17512927.
Maurel J. L., Autin J. M., Funes P., Newman-Tancredi A., Colpaert F., Vacher B. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2007. — October (vol. 50, no. 20). — P. 5024—5033. — doi:10.1021/jm070714l. — PMID17803293.
Monte A. P., Marona-Lewicka D., Lewis M. M., Mailman R. B., Wainscott D. B., Nelson D. L., Nichols D. E. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1998. — June (vol. 41, no. 12). — P. 2134—2145. — doi:10.1021/jm980076u. — PMID9622555.
Romero A. G., Leiby J. A., McCall R. B., Piercey M. F., Smith M. W., Han F. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants. (англ.) // J Med Chem. : journal. — 1993. — Vol. 36, no. 15. — P. 2066—2074. — doi:10.1021/jm00067a003. — PMID8101876.
Jerning E., Svantesson G. T., Mohell N. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. (англ.) // Eur J Pharmacol.[англ.] : journal. — 1998. — Vol. 360, no. 2—3. — P. 219—225. — doi:10.1016/S0014-2999(98)00667-0. — PMID9851589.
Starr K. R., Price G. W., Watson J. M., Atkinson P. J., Arban R., Melotto S., Dawson L. A., Hagan J. J., Upton N., Duxon MS. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. (англ.) // Neuropsychopharmacology. : journal. — 2007. — Vol. 32, no. 10. — P. 2163—2172. — doi:10.1038/sj.npp.1301341. — PMID17356576.
Hamada K., Yoshida M., Isayama H., Yagi Y., Kanazashi S., Kashihara Y., Takeuchi K., Yamaguchi I. Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice (англ.) // Journal of Pharmacological Sciences : journal. — 2007. — November (vol. 105, no. 3). — P. 240—250. — doi:10.1254/jphs.FP0071049. — PMID17965538.
Cliffe I. A., Brightwell C. I., Fletcher A., et al. (S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1993. — May (vol. 36, no. 10). — P. 1509—1510. — doi:10.1021/jm00062a028. — PMID8496920.
A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist (англ.) // Behavioural Brain Research[англ.] : journal. — 1996. — Vol. 73, no. 1—2. — P. 337—333. — doi:10.1016/0166-4328(96)00118-0. — PMID8788530.
Pike V. W., McCarron J. A., Lammerstma A. A., Hume S. P., Poole K., Grasby P. M., Malizia A., Cliffe I. A., Fletcher A., Bench C. J. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635 (англ.) // Eur. J. Pharmacol.[англ.] : journal. — 1995. — Vol. 283, no. 1—3. — P. R1—3. — doi:10.1016/0014-2999(95)00438-Q. — PMID7498295.
Price J. C., Kelley D. E., Ryan C. M., Meltzer C. C., Drevets W. C., Mathis C. A., Mazumdar S., Reynolds C. F. Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study (англ.) // Brain Res.[англ.] : journal. — 2002. — Vol. 927, no. 1. — P. 97—103. — doi:10.1016/S0006-8993(01)03297-8. — PMID11814436.
Burnet P. W., Eastwood S. L., Harrison P. J. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia (англ.) // Neurochem. Int.[англ.] : journal. — 1997. — Vol. 30, no. 6. — P. 565—574. — doi:10.1016/S0197-0186(96)00124-6. — PMID9152998.
Griebel G., Misslin R., Pawlowski M., Guardiola Lemaître B., Guillaumet G., Bizot-Espiard J. Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice. (англ.) // Neuroreport. : journal. — 1992. — Vol. 3, no. 1. — P. 84—86. — doi:10.1097/00001756-199201000-00022. — PMID1351756.
Simon P., Guardiola B., Bizot-Espiard J., Schiavi P., Costentin J. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists. (англ.) // Psychopharmacology[англ.] : journal. — Springer, 1992. — Vol. 108, no. 1—2. — P. 47—50. — doi:10.1007/BF02245284. — PMID1357709.
Astier B., Lambás Señas L., Soulière F., Schmitt P., Urbain N., Rentero N., Bert L., Denoroy L., Renaud B., Lesourd M., Muñoz C., Chouvet G. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. (англ.) // Eur J Pharmacol.[англ.] : journal. — 2003. — Vol. 459, no. 1. — P. 17—26. — doi:10.1016/S0014-2999(02)02814-5. — PMID12505530.
Bardin L., Tarayre J. P., Malfetes N., Koek W., Colpaert F. C. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain (англ.) // Pharmacology : journal. — 2003. — April (vol. 67, no. 4). — P. 182—194. — doi:10.1159/000068404. — PMID12595749.
Bruins Slot L. A., Koek W., Tarayre J. P., Colpaert F. C. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640 (англ.) // European Journal of Pharmacology[англ.] : journal. — 2003. — April (vol. 466, no. 3). — P. 271—279. — doi:10.1016/S0014-2999(03)01566-8. — PMID12694810.
Bardin L., Assié M. B., Pélissou M., Royer-Urios I., Newman-Tancredi A., Ribet J. P., Sautel F., Koek W., Colpaert F. C. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 2005. — March (vol. 312, no. 3). — P. 1034—1042. — doi:10.1124/jpet.104.077669. — PMID15528450.
Deseure K., Bréand S., Colpaert F. C. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist (англ.) // European Journal of Pharmacology[англ.] : journal. — 2007. — July (vol. 568, no. 1—3). — P. 134—141. — doi:10.1016/j.ejphar.2007.04.022. — PMID17512927.
Maurel J. L., Autin J. M., Funes P., Newman-Tancredi A., Colpaert F., Vacher B. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2007. — October (vol. 50, no. 20). — P. 5024—5033. — doi:10.1021/jm070714l. — PMID17803293.
Monte A. P., Marona-Lewicka D., Lewis M. M., Mailman R. B., Wainscott D. B., Nelson D. L., Nichols D. E. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1998. — June (vol. 41, no. 12). — P. 2134—2145. — doi:10.1021/jm980076u. — PMID9622555.
Foreman M. M., Fuller R. W., Rasmussen K., Nelson D. L., Calligaro D. O., Zhang L., Barrett J. E., Booher R. N., Paget C. J., Flaugh M. E. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 1994. — September (vol. 270, no. 3). — P. 1270—1281. — PMID7523657.
Matsuda T., Yoshikawa T., Suzuki M., Asano S., Somboonthum P., Takuma K., Nakano Y., Morita T., Nakasu Y., Kim H. S.Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)aminopropoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.] (англ.) // Japanese journal of pharmacology. — 1995. — Vol. 69, no. 4. — P. 357—366. — PMID8786639. [исправить]
Romero A. G., Leiby J. A., McCall R. B., Piercey M. F., Smith M. W., Han F. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants. (англ.) // J Med Chem. : journal. — 1993. — Vol. 36, no. 15. — P. 2066—2074. — doi:10.1021/jm00067a003. — PMID8101876.
McCall R. B., Romero A. G., Bienkowski M. J., Harris D. W., McGuire J. C., Piercey M. F., Shuck M. E., Smith M. W., Svensson K. A., Schreur P. J., et al. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. (англ.) // J Pharmacol Exp Ther.[англ.] : journal. — 1994. — Vol. 271, no. 2. — P. 875—883. — PMID7965808.
Farré, M; Roset, PN; Llorente, M; Márquez, M; Albet, C; Pérez, JA; Herrero, E; Ortíz, J. A. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration (англ.) // Methods and findings in experimental and clinical pharmacology : journal. — 1997. — Vol. 19, no. 5. — P. 343—350. — PMID9379783.
Montiel, C; Herrero, CJ; García-Palomero, E; Renart, J; García, AG; Lomax, R. B. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors (англ.) // European Journal of Pharmacology[англ.] : journal. — 1997. — Vol. 332, no. 2. — P. 183—193. — doi:10.1016/S0014-2999(97)01073-X. — PMID9286620.
Jerning E., Svantesson G. T., Mohell N. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. (англ.) // Eur J Pharmacol.[англ.] : journal. — 1998. — Vol. 360, no. 2—3. — P. 219—225. — doi:10.1016/S0014-2999(98)00667-0. — PMID9851589.
Starr K. R., Price G. W., Watson J. M., Atkinson P. J., Arban R., Melotto S., Dawson L. A., Hagan J. J., Upton N., Duxon MS. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. (англ.) // Neuropsychopharmacology. : journal. — 2007. — Vol. 32, no. 10. — P. 2163—2172. — doi:10.1038/sj.npp.1301341. — PMID17356576.
Hamada K., Yoshida M., Isayama H., Yagi Y., Kanazashi S., Kashihara Y., Takeuchi K., Yamaguchi I. Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice (англ.) // Journal of Pharmacological Sciences : journal. — 2007. — November (vol. 105, no. 3). — P. 240—250. — doi:10.1254/jphs.FP0071049. — PMID17965538.
Björk L., Cornfield L. J., Nelson D. L., Hillver S. E., Andén N. E., Lewander T., Hacksell U. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. (англ.) // J Pharmacol Exp Ther.[англ.] : journal. — 1991. — Vol. 258, no. 1. — P. 58—65. — PMID1830099.
Cliffe I. A., Brightwell C. I., Fletcher A., et al. (S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1993. — May (vol. 36, no. 10). — P. 1509—1510. — doi:10.1021/jm00062a028. — PMID8496920.
A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist (англ.) // Behavioural Brain Research[англ.] : journal. — 1996. — Vol. 73, no. 1—2. — P. 337—333. — doi:10.1016/0166-4328(96)00118-0. — PMID8788530.
Dedeoğlu, A; Fisher, L. A. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 1991. — Vol. 259, no. 3. — P. 1027—1034. — PMID1762059.
Roth, BL; Driscol, J.PDSP Ki Database (неопр.). Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (12 января 2011). Дата обращения: 4 ноября 2013. Архивировано 8 ноября 2013 года.
Roth, BL; Driscol, J.PDSP Ki Database (неопр.). Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (12 января 2011). Дата обращения: 4 ноября 2013. Архивировано 8 ноября 2013 года.
Pike V. W., McCarron J. A., Lammerstma A. A., Hume S. P., Poole K., Grasby P. M., Malizia A., Cliffe I. A., Fletcher A., Bench C. J. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635 (англ.) // Eur. J. Pharmacol.[англ.] : journal. — 1995. — Vol. 283, no. 1—3. — P. R1—3. — doi:10.1016/0014-2999(95)00438-Q. — PMID7498295.
Price J. C., Kelley D. E., Ryan C. M., Meltzer C. C., Drevets W. C., Mathis C. A., Mazumdar S., Reynolds C. F. Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study (англ.) // Brain Res.[англ.] : journal. — 2002. — Vol. 927, no. 1. — P. 97—103. — doi:10.1016/S0006-8993(01)03297-8. — PMID11814436.
Burnet P. W., Eastwood S. L., Harrison P. J. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia (англ.) // Neurochem. Int.[англ.] : journal. — 1997. — Vol. 30, no. 6. — P. 565—574. — doi:10.1016/S0197-0186(96)00124-6. — PMID9152998.
Simon P., Guardiola B., Bizot-Espiard J., Schiavi P., Costentin J. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists. (англ.) // Psychopharmacology[англ.] : journal. — Springer, 1992. — Vol. 108, no. 1—2. — P. 47—50. — doi:10.1007/BF02245284. — PMID1357709.
Astier B., Lambás Señas L., Soulière F., Schmitt P., Urbain N., Rentero N., Bert L., Denoroy L., Renaud B., Lesourd M., Muñoz C., Chouvet G. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. (англ.) // Eur J Pharmacol.[англ.] : journal. — 2003. — Vol. 459, no. 1. — P. 17—26. — doi:10.1016/S0014-2999(02)02814-5. — PMID12505530.
Bruins Slot L. A., Koek W., Tarayre J. P., Colpaert F. C. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640 (англ.) // European Journal of Pharmacology[англ.] : journal. — 2003. — April (vol. 466, no. 3). — P. 271—279. — doi:10.1016/S0014-2999(03)01566-8. — PMID12694810.
Bardin L., Assié M. B., Pélissou M., Royer-Urios I., Newman-Tancredi A., Ribet J. P., Sautel F., Koek W., Colpaert F. C. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 2005. — March (vol. 312, no. 3). — P. 1034—1042. — doi:10.1124/jpet.104.077669. — PMID15528450.
Deseure K., Bréand S., Colpaert F. C. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist (англ.) // European Journal of Pharmacology[англ.] : journal. — 2007. — July (vol. 568, no. 1—3). — P. 134—141. — doi:10.1016/j.ejphar.2007.04.022. — PMID17512927.
Maurel J. L., Autin J. M., Funes P., Newman-Tancredi A., Colpaert F., Vacher B. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2007. — October (vol. 50, no. 20). — P. 5024—5033. — doi:10.1021/jm070714l. — PMID17803293.
Monte A. P., Marona-Lewicka D., Lewis M. M., Mailman R. B., Wainscott D. B., Nelson D. L., Nichols D. E. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1998. — June (vol. 41, no. 12). — P. 2134—2145. — doi:10.1021/jm980076u. — PMID9622555.
Foreman M. M., Fuller R. W., Rasmussen K., Nelson D. L., Calligaro D. O., Zhang L., Barrett J. E., Booher R. N., Paget C. J., Flaugh M. E. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 1994. — September (vol. 270, no. 3). — P. 1270—1281. — PMID7523657.
McCall R. B., Romero A. G., Bienkowski M. J., Harris D. W., McGuire J. C., Piercey M. F., Shuck M. E., Smith M. W., Svensson K. A., Schreur P. J., et al. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. (англ.) // J Pharmacol Exp Ther.[англ.] : journal. — 1994. — Vol. 271, no. 2. — P. 875—883. — PMID7965808.
Björk L., Cornfield L. J., Nelson D. L., Hillver S. E., Andén N. E., Lewander T., Hacksell U. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. (англ.) // J Pharmacol Exp Ther.[англ.] : journal. — 1991. — Vol. 258, no. 1. — P. 58—65. — PMID1830099.
Cliffe I. A., Brightwell C. I., Fletcher A., et al. (S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 1993. — May (vol. 36, no. 10). — P. 1509—1510. — doi:10.1021/jm00062a028. — PMID8496920.
A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist (англ.) // Behavioural Brain Research[англ.] : journal. — 1996. — Vol. 73, no. 1—2. — P. 337—333. — doi:10.1016/0166-4328(96)00118-0. — PMID8788530.
Dedeoğlu, A; Fisher, L. A. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms (англ.) // The Journal of Pharmacology and Experimental Therapeutics[англ.] : journal. — 1991. — Vol. 259, no. 3. — P. 1027—1034. — PMID1762059.
Matsuda T., Yoshikawa T., Suzuki M., Asano S., Somboonthum P., Takuma K., Nakano Y., Morita T., Nakasu Y., Kim H. S.Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)aminopropoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.] (англ.) // Japanese journal of pharmacology. — 1995. — Vol. 69, no. 4. — P. 357—366. — PMID8786639. [исправить]
